Concepedia
Statistics
Publications
16
Citations
1.3K
H-Index
14
Active since
1995
Affiliations
Cancer Research UK(Current)
Newcastle University
Beatson West of Scotland Cancer Centre
University of Glasgow
Aberdeen Royal Infirmary
L Robson is an author at Cancer Research UK specializing in pharmacology, medicine, and oncology.
Publications per year
1995–2020
Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors
Ruth Plummer, Christopher J. Jones, Mark R. Middleton et al. · Clinical Cancer Research · 2008 · 384 citations · Full text
Medicine, Oncology, Pharmacology +15
Antitumor activity without on-target off-tumor toxicity of GD2–chimeric antigen receptor T cells in patients with neuroblastoma
Karin Straathof, Barry Flutter, Rebecca Wallace et al. · Science Translational Medicine · 2020 · 205 citations
Life Sciences, Immunology, Oncology +17
Phase I and pharmacokinetic (PK) study of MAG-CPT (PNU 166148): a polymeric derivative of camptothecin (CPT)
D. Bissett, J Cassidy, Johann S. de Bono et al. · British Journal of Cancer · 2004 · 125 citations · Full text
Medicine, Oncology, Pharmacology +17
A Phase I and Pharmacokinetic Study of Paclitaxel Poliglumex (XYOTAX), Investigating Both 3-Weekly and 2-Weekly Schedules
Alan V. Boddy, E. Ruth Plummer, R Todd et al. · Clinical Cancer Research · 2005 · 108 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +17
Phase I Trial of AEG35156 Administered as a 7-Day and 3-Day Continuous Intravenous Infusion in Patients With Advanced Refractory Cancer
Emma Dean, Duncan I. Jodrell, Kate Connolly et al. · Journal of Clinical Oncology · 2009 · 93 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
1–5 of 16